November 20,2007
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety.
Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global Health Program at the Bill and Melinda Gates Foundation. Dr. John Buse was a professor of medicine at the University of North Carolina in 1999, when he expressed concerns about the diabetes drug Avandia, which is made by GlaxoSmithKline.
###
Next Article Previous Article
Recent News
- Wyden Hails Senate Passage of Legislation to Reauthorize & Modernize Title IV-B to Better Support Children and Families in America
- Wyden, Durbin, Brown Investigate Trump Advisor Boris Epshteyn’s Cash for Cabinet Appointment Scheme
- Wyden Urges GAO to Investigate the Deceptive Marketing Schemes of Youth Residential Treatment Facilities
- Wyden Investigation Highlights Dangers of Post-Dobbs Emergency Medical Care for Pregnant Women
- Wyden, Ossoff, Warnock Seek Watchdog Investigation into Waste and Mismanagement in Georgia Pathways Program